Mitchell Robinson: Everything you need to know

Mitchell Robinson

#23 C

New York Knicks

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

7.5

8.0

0.7

1.7

0.9

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	60	16	19.6	5.7	8.8	0.9	1.2	0.9	0.7	6	0.0%	2.5	3.4	72.3%	2.5	3.4	72.3%	0.7	1.7	40.8%	4.2	4.6	2.1	1.3	+157	67.6%
2024-25	17	3	17.1	5.1	5.9	0.8	1.1	0.9	0.6	2	0.0%	2.2	3.3	66.1%	2.2	3.3	66.1%	0.8	1.1	68.4%	3.1	2.9	1.5	1.3	+23	67.6%
2023-24	31	21	24.8	5.6	8.5	0.6	1.1	1.2	0.8	2	0.0%	2.4	4.1	57.5%	2.4	4.1	57.5%	0.9	2.1	40.9%	4.6	3.9	1.8	0.7	+13	55.4%
2022-23	59	58	26.9	7.4	9.4	0.9	1.8	0.9	0.7	13	0.0%	3.2	4.7	67.1%	3.2	4.7	67.1%	1.0	2.1	48.4%	4.5	4.9	2.7	1.3	+185	65.2%
2021-22	72	62	25.7	8.5	8.6	0.5	1.8	0.8	0.8	20	0.0%	3.6	4.8	76.1%	3.6	4.8	76.1%	1.2	2.5	48.6%	4.1	4.5	2.7	0.6	-81	72.2%
2020-21	31	29	27.5	8.3	8.1	0.5	1.5	1.1	0.8	5	0.0%	3.7	5.7	65.3%	3.7	5.7	65.3%	0.8	1.7	49.1%	3.6	4.5	2.8	0.7	-17	64.2%
2019-20	61	7	23.1	9.7	7.0	0.6	2.0	0.9	0.6	8	0.0%	4.1	5.6	74.2%	4.1	5.6	74.2%	1.4	2.4	56.8%	3.0	4.0	3.2	1.0	-107	72.6%
2018-19	66	19	20.6	7.3	6.4	0.6	2.4	0.8	0.5	11	0.0%	3.1	4.4	69.4%	3.1	4.4	69.4%	1.2	2.0	60.0%	2.7	3.7	3.3	1.1	-203	69.2%
Career	397	215	23.4	7.5	8.0	0.7	1.7	0.9	0.7	67	0.0%	3.2	4.6	70.2%	3.2	4.6	70.2%	1.1	2.1	50.8%	3.7	4.2	2.7	1.0	-30	68.1%

Career Averages

PTS

REB

AST

BLK

STL

5.0

7.0

0.5

1.0

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	12	0	13.8	5.1	5.1	0.3	0.7	0.4	0.3	0	0.0%	2.0	2.7	75.0%	2.0	2.7	75.0%	1.1	3.4	31.7%	2.3	2.8	1.7	1.0	+53	61.0%
2024-25	18	4	20.6	4.7	7.1	0.4	0.8	0.9	0.7	1	0.0%	1.7	2.8	60.8%	1.7	2.8	60.8%	1.2	3.1	39.3%	3.7	3.3	2.1	0.5	+7	55.5%
2023-24	6	0	19.2	2.8	6.8	0.5	1.2	1.0	0.5	0	0.0%	1.2	2.3	50.0%	1.2	2.3	50.0%	0.5	1.3	37.5%	3.8	3.0	2.5	1.0	+30	48.5%
2022-23	11	11	27.1	6.5	9.3	0.8	1.5	0.7	0.9	2	0.0%	2.6	4.4	60.4%	2.6	4.4	60.4%	1.2	3.0	39.4%	5.0	4.3	2.6	0.9	-1	56.8%
Career	47	15	20.2	5.0	7.0	0.5	1.0	0.8	0.6	3	0.0%	1.9	3.1	62.8%	1.9	3.1	62.8%	1.1	2.9	37.0%	3.7	3.4	2.2	0.8	+89	56.6%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/9	MIN	W 100-95	12	1	6	0	1	1	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	2	1	50.0%	1	5	0.0	-5	0	9	56.8%
10/4	PHI	W 113-104	13	6	8	0	0	0	1	0	0	0.0%	5	3	60.0%	5	3	60.0%	2	0	0.0%	3	5	0.0	+16	2	7	51.0%
10/2	PHI	W 99-84	18	7	16	1	1	1	1	0	0	0.0%	6	3	50.0%	6	3	50.0%	2	1	50.0%	5	11	1.0	+5	1	21	50.9%
Preseason Totals			14.8	4.7	10.0	0.3	0.7	0.7	0.7	0.0	0.0	0.0%	3.7	2.0	54.5%	3.7	2.0	54.5%	2.0	0.7	33.3%	3.0	7.0	0.5	+16	1.0	13.7	51.3%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/9	BOS	W 112-106	18	7	7	0	1	3	0	0	0	0.0%	4	3	75.0%	4	3	75.0%	2	1	50.0%	2	5	0.0	-2	3	17	71.7%
4/6	ATL	W 108-105	19	8	12	1	3	2	0	0	0	0.0%	6	4	66.7%	6	4	66.7%	0	0	0.0%	4	8	0.0	+4	1	23	66.7%
4/3	CHI	W 136-96	22	17	11	0	1	2	0	0	0	0.0%	7	7	100.0%	7	7	100.0%	4	3	75.0%	5	6	0.0	+13	2	31	97.0%
3/31	HOU	L 111-94	15	5	5	0	0	1	0	0	0	0.0%	4	2	50.0%	4	2	50.0%	2	1	50.0%	2	3	0.0	-14	3	6	51.2%
3/29	OKC	L 111-100	17	3	4	0	2	0	1	0	0	0.0%	3	1	33.3%	3	1	33.3%	2	1	50.0%	2	2	0.0	+2	1	5	38.7%
3/26	CHA	L 114-103	26	4	6	1	1	1	1	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	2	4	1.0	+8	3	9	100.0%
3/24	NOP	W 121-116	20	11	8	0	2	1	1	0	0	0.0%	5	5	100.0%	5	5	100.0%	1	1	100.0%	4	4	0.0	+11	2	20	101.1%
3/22	WAS	W 145-113	16	10	10	1	2	0	0	0	0	0.0%	5	5	100.0%	5	5	100.0%	0	0	0.0%	3	7	0.0	+14	0	24	100.0%
3/20	BKN	W 93-92	23	3	10	0	3	1	2	0	0	0.0%	2	1	50.0%	2	1	50.0%	5	1	20.0%	4	6	0.0	-13	3	9	35.7%
3/17	IND	W 136-110	18	8	8	3	0	1	1	0	0	0.0%	5	4	80.0%	5	4	80.0%	1	0	0.0%	5	3	3.0	+3	1	17	73.5%
3/15	GSW	W 110-107	17	4	10	0	2	3	2	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	3	7	0.0	-6	0	17	100.0%
3/13	IND	W 101-92	30	12	22	0	2	2	3	0	0	0.0%	10	6	60.0%	10	6	60.0%	0	0	0.0%	9	13	0.0	+20	2	27	60.0%
3/11	UTA	W 134-117	22	6	13	3	0	1	0	0	0	0.0%	4	3	75.0%	4	3	75.0%	0	0	0.0%	5	8	0.0	+16	0	22	75.0%
3/8	LAL	L 110-97	16	4	4	0	0	1	0	0	0	0.0%	3	2	66.7%	3	2	66.7%	0	0	0.0%	2	2	0.0	-11	1	8	66.7%
3/6	DEN	W 142-103	14	13	5	1	0	0	1	0	0	0.0%	7	6	85.7%	7	6	85.7%	2	1	50.0%	4	1	1.0	+12	4	14	82.5%
3/3	TOR	W 111-95	20	2	10	0	0	2	1	0	0	0.0%	1	1	100.0%	1	1	100.0%	0	0	0.0%	2	8	0.0	+0	1	14	100.0%
3/1	SAS	W 114-89	15	4	5	0	1	1	2	0	0	0.0%	2	2	100.0%	2	2	100.0%	3	0	0.0%	2	3	0.0	+10	1	8	60.2%
2/27	MIL	W 127-98	15	0	3	3	2	1	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	1	2	0.0	+10	1	8	0.0%
2/24	CLE	L 109-94	19	11	16	1	2	0	0	0	0	0.0%	6	5	83.3%	6	5	83.3%	4	1	25.0%	8	8	0.0	-4	2	25	70.9%
2/21	HOU	W 108-106	17	6	4	0	0	0	1	0	0	0.0%	5	3	60.0%	5	3	60.0%	0	0	0.0%	3	1	0.0	-21	3	4	60.0%
2/19	DET	L 126-111	19	7	6	0	1	2	0	0	0	0.0%	4	2	50.0%	4	2	50.0%	6	3	50.0%	4	2	0.0	-15	1	12	52.7%
2/11	PHI	W 138-89	15	11	6	0	4	0	1	0	0	0.0%	3	3	100.0%	3	3	100.0%	8	5	62.5%	3	3	0.0	+15	2	19	84.4%
2/8	BOS	W 111-89	15	5	9	2	0	0	0	0	0	0.0%	2	1	50.0%	2	1	50.0%	8	3	37.5%	2	7	0.0	+15	1	15	45.3%
2/6	DET	L 118-80	20	4	3	0	0	0	0	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	0	3	0.0	-14	3	3	100.0%
2/4	DEN	W 134-127	23	10	8	0	1	1	0	0	0	0.0%	5	5	100.0%	5	5	100.0%	0	0	0.0%	1	7	0.0	+3	5	17	100.0%
2/1	LAL	W 112-100	23	0	7	1	1	0	1	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	3	4	1.0	+0	0	7	0.0%
1/30	POR	W 127-97	17	2	7	2	0	0	1	0	0	0.0%	1	1	100.0%	1	1	100.0%	0	0	0.0%	4	3	2.0	-1	3	7	100.0%
1/27	SAC	W 103-87	26	7	13	0	0	2	0	0	0	0.0%	5	3	60.0%	5	3	60.0%	2	1	50.0%	6	7	0.0	+25	1	19	59.5%
1/24	PHI	W 112-109	26	6	10	0	2	2	0	0	0	0.0%	4	3	75.0%	4	3	75.0%	0	0	0.0%	6	4	0.0	+14	4	15	75.0%
1/21	BKN	W 120-66	16	7	7	0	2	1	1	0	0	0.0%	3	3	100.0%	3	3	100.0%	2	1	50.0%	3	4	0.0	+20	3	13	90.2%
1/19	DAL	L 114-97	18	12	14	0	2	0	1	0	0	0.0%	8	6	75.0%	8	6	75.0%	2	0	0.0%	8	6	0.0	-11	4	20	67.6%
1/17	PHX	L 106-99	19	1	10	2	1	0	1	0	0	0.0%	1	0	0.0%	1	0	0.0%	4	1	25.0%	5	5	2.0	-5	3	8	18.1%
1/14	SAC	L 112-101	19	8	11	0	1	1	0	0	0	0.0%	3	3	100.0%	3	3	100.0%	4	2	50.0%	7	4	0.0	-3	3	18	84.0%
1/11	POR	W 123-114	25	6	11	2	3	3	0	0	0	0.0%	5	3	60.0%	5	3	60.0%	0	0	0.0%	6	5	0.0	+11	1	20	60.0%
1/9	PHX	L 112-107	24	8	14	1	0	0	1	0	0	0.0%	5	4	80.0%	5	4	80.0%	0	0	0.0%	8	6	1.0	+0	3	18	80.0%
1/7	LAC	W 123-111	24	4	9	1	2	0	0	0	0	0.0%	5	2	40.0%	5	2	40.0%	0	0	0.0%	5	4	0.0	+14	1	13	40.0%
1/5	DET	L 121-90	24	2	10	1	1	0	0	0	0	0.0%	3	1	33.3%	3	1	33.3%	0	0	0.0%	3	7	0.0	-10	1	11	33.3%
1/3	PHI	L 130-119	18	2	5	2	0	2	1	0	0	0.0%	2	1	50.0%	2	1	50.0%	1	0	0.0%	3	2	2.0	-11	5	4	41.0%
12/27	ATL	W 128-125	18	6	9	1	1	2	0	0	0	0.0%	3	3	100.0%	3	3	100.0%	0	0	0.0%	4	5	0.0	+10	1	19	100.0%
12/25	CLE	W 126-124	16	0	13	2	1	0	1	0	0	0.0%	1	0	0.0%	1	0	0.0%	2	0	0.0%	8	5	2.0	+0	2	12	0.0%
12/23	MIN	L 115-104	26	2	7	1	2	1	2	0	0	0.0%	4	1	25.0%	4	1	25.0%	0	0	0.0%	6	1	0.5	-15	3	7	25.0%
12/21	MIA	W 132-125	22	9	7	2	1	2	0	0	0	0.0%	4	3	75.0%	4	3	75.0%	3	3	100.0%	2	5	0.0	+6	3	19	84.6%
12/19	PHI	L 116-107	26	21	16	1	2	1	1	0	0	0.0%	8	7	87.5%	8	7	87.5%	8	7	87.5%	6	10	1.0	+2	2	40	91.1%
12/13	ORL	W 132-120	17	5	9	0	4	0	0	0	0	0.0%	2	2	100.0%	2	2	100.0%	2	1	50.0%	4	5	0.0	+4	0	18	86.8%
12/9	TOR	W 117-101	15	2	5	4	1	1	2	0	0	0.0%	0	0	0.0%	0	0	0.0%	8	2	25.0%	4	1	2.0	-6	5	4	28.4%
12/7	ORL	W 106-100	24	6	13	2	1	1	1	0	0	0.0%	4	3	75.0%	4	3	75.0%	0	0	0.0%	8	5	2.0	+8	3	20	75.0%
12/5	UTA	W 146-112	16	4	7	1	1	2	1	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	3	4	1.0	+13	1	14	100.0%
12/2	BOS	L 123-117	15	1	5	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	4	1	25.0%	4	1	0.0	-14	0	7	28.4%
11/30	TOR	W 116-94	16	2	15	0	0	0	0	0	0	0.0%	4	1	25.0%	4	1	25.0%	2	0	0.0%	7	8	0.0	+17	1	12	20.5%
11/28	MIL	W 118-109	18	6	7	1	0	2	2	0	0	0.0%	3	3	100.0%	3	3	100.0%	2	0	0.0%	3	4	0.5	-4	2	12	77.3%
11/26	CHA	W 129-101	17	0	5	1	1	3	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	5	0.0	+18	1	9	0.0%
11/22	ORL	L 133-121	16	6	3	0	2	0	1	0	0	0.0%	3	3	100.0%	3	3	100.0%	0	0	0.0%	1	2	0.0	-3	4	6	100.0%
11/19	DAL	W 113-111	21	3	8	1	1	0	1	0	0	0.0%	1	1	100.0%	1	1	100.0%	6	1	16.7%	3	5	1.0	-12	2	9	41.2%
11/17	MIA	L 115-113	18	5	11	1	0	1	1	0	0	0.0%	3	2	66.7%	3	2	66.7%	2	1	50.0%	5	6	1.0	+4	2	14	64.4%
11/14	MIA	W 140-132	14	0	10	2	0	0	2	0	0	0.0%	2	0	0.0%	2	0	0.0%	0	0	0.0%	8	2	1.0	-5	5	4	0.0%
11/12	ORL	L 124-107	17	2	8	0	0	0	0	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	5	3	0.0	-11	4	6	50.0%
11/9	BKN	W 134-98	16	8	8	0	2	2	0	0	0	0.0%	4	4	100.0%	4	4	100.0%	0	0	0.0%	3	5	0.0	+40	3	18	100.0%
11/5	MIN	W 137-114	16	8	10	1	3	1	1	0	0	0.0%	5	4	80.0%	5	4	80.0%	1	0	0.0%	9	1	1.0	+7	1	20	73.5%
11/2	CHI	W 128-116	13	0	5	1	2	0	0	0	0	0.0%	3	0	0.0%	3	0	0.0%	0	0	0.0%	4	1	0.0	-1	1	4	0.0%
10/31	CHI	L 135-125	19	4	11	2	0	0	1	0	0	0.0%	3	2	66.7%	3	2	66.7%	0	0	0.0%	6	5	2.0	+0	3	12	66.7%
Regular Season Totals			19.6	5.7	8.8	0.9	1.2	0.9	0.7	0.0	0.0	0.0%	3.4	2.5	72.3%	3.4	2.5	72.3%	1.7	0.7	40.8%	4.2	4.6	1.3	+157	2.1	16.2	67.6%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/23	CLE	W 121-108	9	2	3	0	0	0	0	0	0	0.0%	1	1	100.0%	1	1	100.0%	0	0	0.0%	1	2	0.0	-4	3	3	100.0%
5/21	CLE	W 109-93	12	4	4	0	1	0	1	0	0	0.0%	2	2	100.0%	2	2	100.0%	4	0	0.0%	1	3	0.0	-1	1	6	53.2%
5/19	CLE	W 115-104	14	4	6	1	0	2	0	0	0	0.0%	3	1	33.3%	3	1	33.3%	8	2	25.0%	4	2	0.0	-8	1	8	30.7%
5/10	PHI	W 144-114	16	6	6	0	0	0	0	0	0	0.0%	4	2	50.0%	4	2	50.0%	4	2	50.0%	4	2	0.0	+14	2	9	52.1%
5/8	PHI	W 108-94	18	6	6	0	1	1	0	0	0	0.0%	3	1	33.3%	3	1	33.3%	8	4	50.0%	2	4	0.0	+16	2	12	46.0%
5/4	PHI	W 137-98	11	2	4	1	0	0	0	0	0	0.0%	1	1	100.0%	1	1	100.0%	4	0	0.0%	0	4	0.0	+6	4	1	36.2%
4/30	ATL	W 140-89	8	6	3	0	2	0	0	0	0	0.0%	3	3	100.0%	3	3	100.0%	0	0	0.0%	2	1	0.0	+29	1	9	100.0%
4/28	ATL	W 126-97	15	7	6	0	1	0	2	0	0	0.0%	3	3	100.0%	3	3	100.0%	4	1	25.0%	2	4	0.0	+19	2	11	73.5%
4/25	ATL	W 114-98	15	6	8	1	0	0	0	0	0	0.0%	3	2	66.7%	3	2	66.7%	3	2	66.7%	5	3	0.0	+5	1	14	69.4%
4/23	ATL	L 109-108	11	2	4	0	0	1	0	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	2	2	0.0	-18	0	6	50.0%
4/20	ATL	L 107-106	18	13	7	0	1	1	1	0	0	0.0%	6	6	100.0%	6	6	100.0%	2	1	50.0%	4	3	0.0	-10	2	19	94.5%
4/18	ATL	W 113-102	14	3	4	1	2	0	0	0	0	0.0%	1	1	100.0%	1	1	100.0%	4	1	25.0%	0	4	0.0	+5	1	9	54.3%
Postseason Totals			13.8	5.1	5.1	0.3	0.7	0.4	0.3	0.0	0.0	0.0%	2.7	2.0	75.0%	2.7	2.0	75.0%	3.4	1.1	31.7%	2.3	2.8	1.0	+53	1.7	10.8	61.0%

Mitchell Robinson: Breaking News

Robinson (illness) will play in Game 3 of the Eastern Conference Semifinals against the 76ers on Friday, James L. Edwards III of The Athletic reports. Robinson missed Wednesday's Game 2 win with an illness, but he'll be back in action Friday and should see his usual minutes behind Karl-Anthony Towns. Robinson is averaging 6.0 points, 5.0 rebounds and 1.0 blocks per game this postseason.

Robinson (illness) is probable for Friday's Game 3 of the Eastern Conference Semifinals against the 76ers. Robinson was a late addition to the injury report ahead of Game 2 and ended up sitting out the narrow win, but he's expected to return to action Friday. Across seven playoff games, Robinson has averaged 5.6 points, 5.1 rebounds and 0.9 blocks in 13.6 minutes.

Robinson (illness) is out Wednesday for Game 2 of the Eastern Conference Semifinals against the 76ers, Stefan Bondy of The New York Post reports. Robinson will hope to feel better in time for Game 3 on Friday, when the series flips to Philadelphia. Fresh off pulling down a postseason-high nine boards in Game 1, Ariel Hukporti should assume the top backup center role behind Karl-Anthony Towns on Wednesday.